ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,475Medicare Part D Prescriptions Filled, Including Refills

Rank: 148 out of 890

$802K Total Retail Price of All Prescriptions

Rank: 98 out of 890

402 Patients Receiving at Least One Drug in Part D
73%Patients 65 Years and Older
70% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 402 patients filled at least one prescription for a schedule two drug, compared to an average of 2%.

Schedule Three
Controlled Substances

20% of this provider’s 402 patients filled at least one prescription for a schedule three drug, compared to an average of 15%.

Risky Drugs to Seniors

2% of this provider’s 8,970 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

34% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
FUROSEMIDE 320 232 1 7
ZOLPIDEM TARTRATE 313 186 2 19
HYDROCODONE-ACETAMINOPHEN 276 188 S3 3 3
AMLODIPINE BESYLATE 275 222 4 1
LEVOTHYROXINE SODIUM 267 194 5 2
MELOXICAM 255 211 6 18
METFORMIN HCL 251 165 7 6
GABAPENTIN 231 167 8 12
OMEPRAZOLE 205 172 9 8
POTASSIUM CHLORIDE 204 152 10 11
LISINOPRIL 203 178 11 4
SIMVASTATIN 185 162 12 5
AMLODIPINE BESYLATE-BENAZEPRIL 181 110 13 41
TRAZODONE HCL 157 90 14 40
TRAMADOL HCL 157 91 14 16
HYDROCHLOROTHIAZIDE 147 115 16 9
CRESTOR 145 98 17 25
RANITIDINE HCL 135 111 18 49
SERTRALINE HCL 133 110 19 26
DEXILANT 133 86 19 138
CARVEDILOL 124 118 21 22
NEXIUM 120 72 22 14
METOPROLOL TARTRATE 116 98 23 15
TAMSULOSIN HCL 110 100 24 32
POLYETHYLENE GLYCOL 3350 103 82 25 67
TRILIPIX 100 79 26 200
CLOPIDOGREL 100 90 26 28
TRAMADOL HCL-ACETAMINOPHEN 99 88 28 117
DONEPEZIL HCL 99 99 28 30
DIOVAN 98 79 30 33
JANUVIA 96 76 31 59
DIOVAN HCT 96 69 31 48
WARFARIN SODIUM 92 58 33 24
ATORVASTATIN CALCIUM 91 62 34 13
LOVAZA 82 68 35 120
ONGLYZA 82 66 35 146
FLUOXETINE HCL 80 45 37 63
METOPROLOL SUCCINATE 80 61 37 17
LEVOCETIRIZINE DIHYDROCHLORIDE 78 48 39 131
DICLOFENAC SODIUM 77 36 40 96
ESCITALOPRAM OXALATE 76 43 41 51
AMITRIPTYLINE HCL 74 58 R 42 43
CYMBALTA 72 40 43 45
SINGULAIR 72 50 43 79
PROAIR HFA 71 37 45 55
LIPITOR 71 38 45 77
ADVAIR DISKUS 69 43 47 52
LYRICA 68 53 48 71
SYNTHROID 68 55 48 53
GLIPIZIDE 68 68 48 62
ATENOLOL 61 49 51 23
LISINOPRIL-HYDROCHLOROTHIAZIDE 60 57 52 21
ABILIFY 60 35 52 172
ENABLEX 59 59 54 248
FLUTICASONE PROPIONATE 59 20 54 39
PLAVIX 58 46 56 42
ALLOPURINOL 55 38 57 31
CYCLOBENZAPRINE HCL 55 25 R 57 64
MECLIZINE HCL 54 52 59 97
NAMENDA 53 53 60 36
ROPINIROLE HCL 53 41 60 93
AVODART 53 37 60 198
FENOFIBRATE 52 29 63 74
METOLAZONE 52 27 63 217
FINASTERIDE 51 47 65 108
CARISOPRODOL 50 14 R 66 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.